Syros Pharmaceuticals (SYRS) Earnings
|
Expand Research on SYRS
| Next EPS Date | 7/29/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +40.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/26  |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/27/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/26/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/25/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/19/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/28/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 |
Q425 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A |
